Recent news on Pergolide Mesylate

Pergolide Gourmeds  -  25 May 2007
PR Newswire (press release),SWEDESBORO, NJ, May 24 /PRNewswire/ -- The March 29 voluntary withdrawal of pergolide mesylate, a drug used to treat Parkinson's disease,

Pergolide Availability: No FDA Announcement, Supplies Running Low  -  May 4, 2007
TheHorse.com,More than a month since pergolide mesylate, a drug commonly used to treat pituitary pars intermedia dysfunction (PPID), also known as equine Cushing's

Pergolide: Veterinarians, Horse Owners Fighting for Availability  -  Apr 17, 2007
TheHorse.com,Pergolide mesylate, a drug commonly used to treat pituitary pars intermedia dysfunction (PPID), also known as equine Cushing's disease, has been withdrawn

Parkinson's drug withdrawn  -  Mar 30, 2007
CBC Manitoba,Pergolide mesylate, sold under the brand name Permax by Eli Lilly and Co., is in a class of drugs called dopamine agonists, which stimulate the brain

Permax Pulled from the Market  -  Mar 29, 2007
Lawyers and Settlements,Permax (Generic name: pergolide mesylate), manufactured by Eli Lilly, has been prescribed to millions of people since it was approved in 1989 to treat

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional